Log-in
Sign-up
Webcast
Clinical Trials
Library
Webcast
Clinical Trials
Library
Home
>
Clinical Trials
Molecules
전체
Edoxaban
Olmesartan
Prasugrel
Pravastatin
Mirogabalin
Ramosetron
Trastuzumab deruxtecan
Status
Select
Check All
Search
Recruiting
Completed
Not yet recruiting
Enrolling by invitation
Active, not recruiting
Suspended
Terminated
Withdrawn
Unknown status
Email
Saved trials
ACTIVE_NOT_RECRUITING
NCT04538742
A Phase 1b/2 Study of T-DXd Combinations in HER2-positive Metastatic Breast Cancer
245
Enrollment(s)
72
Study location(s)
INTERVENTIONAL (PHASE1|||PHASE2)
Metastatic Breast Cancer
COMPLETED
NCT04526704
Study to Evaluate Discontinuation and Re-Treatment in Participants With Tenosynovial Giant Cell Tumor (TGCT) Previously Treated With Pexidartinib
32
Enrollment(s)
16
Study location(s)
INTERVENTIONAL (PHASE4)
Tenosynovial Giant Cell Tumor
RECRUITING
NCT04379596
Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2-expressing Gastric Cancer (DESTINY-Gastric03)
413
Enrollment(s)
100
Study location(s)
INTERVENTIONAL (PHASE2)
Gastric Cancer
RECRUITING
NCT04356209
Improving Theempowerment in Patients With Severe Breast Fibrosis Radio-induced Treated by Pravastatin : Benefit of e-PROs (Electronic " Patient Reported Outcome ") on Breast-related Quality of Life
105
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE2)
Breast Cancer
TERMINATED
NCT04100135
GORE® CARDIOFORM Septal Occluder Migraine Clinical Study
7
Enrollment(s)
15
Study location(s)
INTERVENTIONAL (NA)
Migraine
Patent Foramen Ovale
PFO - Patent Foramen Ovale
ACTIVE_NOT_RECRUITING
NCT04042701
DS8201a and Pembrolizumab in Participants With Locally Advanced/Metastatic Breast or Non-Small Cell Lung Cancer
115
Enrollment(s)
30
Study location(s)
INTERVENTIONAL (PHASE1)
Breast Cancer
Non-small Cell Lung Carcinoma
COMPLETED
NCT03996772
PREvention of STroke in Intracerebral haemorrhaGE Survivors With Atrial Fibrillation
319
Enrollment(s)
64
Study location(s)
INTERVENTIONAL (PHASE3)
Atrial Fibrillation
Intracerebral Hemorrhage
ACTIVE_NOT_RECRUITING
NCT03950076
EdoxabaN for IntraCranial Hemorrhage Survivors with Atrial Fibrillation (ENRICH-AF)
948
Enrollment(s)
152
Study location(s)
INTERVENTIONAL (PHASE4)
Intracranial Hemorrhages
Atrial Fibrillation
16
17
18
19
20